Return On Equity of BIOCEPT INC from 31 Dec 2013 to 30 Jun 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BIOCEPT INC quarterly and annual Return On Equity in % history and change rate from 31 Dec 2013 to 30 Jun 2023.
  • BIOCEPT INC Return On Equity for the quarter ending 30 Jun 2023 was -412%, a 817% decline year-over-year.
  • BIOCEPT INC annual Return On Equity for 2022 was -140%, a 1543% decline from 2021.
  • BIOCEPT INC annual Return On Equity for 2021 was -8.5%, a 89% increase from 2020.
  • BIOCEPT INC annual Return On Equity for 2020 was -76%, a 65% increase from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

BIOCEPT INC Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2023 -412% -367% -817% 01 Apr 2023 30 Jun 2023
Q1 2023 -259% -238% -1114% 01 Jan 2023 31 Mar 2023
Q4 2022 -140% -131% -1543% 01 Oct 2022 31 Dec 2022
Q3 2022 -84% -91% -1322% 01 Jul 2022 30 Sep 2022
Q2 2022 -45% -36% -415% 01 Apr 2022 30 Jun 2022
Q1 2022 -21% +6.7% +24% 01 Jan 2022 31 Mar 2022
Q4 2021 -8.5% +67% +89% 01 Oct 2021 31 Dec 2021
Q3 2021 6.9% +132% 01 Jul 2021 30 Sep 2021
Q2 2021 -8.7% +146% +94% 01 Apr 2021 30 Jun 2021
Q1 2021 -28% +173% +86% 01 Jan 2021 31 Mar 2021
Q4 2020 -76% +143% +65% 01 Oct 2020 31 Dec 2020
Q3 2020 -125% +144% +53% 01 Jul 2020 30 Sep 2020
Q2 2020 -155% +109% +41% 01 Apr 2020 30 Jun 2020
Q1 2020 -201% +137% +40% 01 Jan 2020 31 Mar 2020
Q4 2019 -218% +209% +49% 01 Oct 2019 31 Dec 2019
Q3 2019 -269% +187% +41% 01 Jul 2019 30 Sep 2019
Q2 2019 -264% +323% +55% 01 Apr 2019 30 Jun 2019
Q1 2019 -338% +106% +24% 01 Jan 2019 31 Mar 2019
Q4 2018 -427% -52% -14% 01 Oct 2018 31 Dec 2018
Q3 2018 -456% -97% -27% 01 Jul 2018 30 Sep 2018
Q2 2018 -587% -37% -6.7% 01 Apr 2018 30 Jun 2018
Q1 2018 -445% +733% +62% 01 Jan 2018 31 Mar 2018
Q4 2017 -375% -1906% -124% 01 Oct 2017 31 Dec 2017
Q3 2017 -359% -4609% -108% 01 Jul 2017 30 Sep 2017
Q2 2017 -550% +216% +28% 01 Apr 2017 30 Jun 2017
Q1 2017 -1177% -837% -246% 01 Jan 2017 31 Mar 2017
Q4 2016 1531% +1724% 01 Oct 2016 31 Dec 2016
Q3 2016 4250% +4457% 01 Jul 2016 30 Sep 2016
Q2 2016 -765% -541% -241% 01 Apr 2016 30 Jun 2016
Q1 2016 -340% -93% -38% 01 Jan 2016 31 Mar 2016
Q4 2015 -192% +136% +41% 01 Oct 2015 31 Dec 2015
Q3 2015 -207% +610% +75% 01 Jul 2015 30 Sep 2015
Q2 2015 -225% -1051% -127% 01 Apr 2015 30 Jun 2015
Q1 2015 -247% -477% -207% 01 Jan 2015 31 Mar 2015
Q4 2014 -329% -390% -636% 01 Oct 2014 31 Dec 2014
Q3 2014 -817% 01 Jul 2014 30 Sep 2014
Q2 2014 826% 01 Apr 2014 30 Jun 2014
Q1 2014 230% 01 Jan 2014 31 Mar 2014
Q4 2013 61% 01 Oct 2013 31 Dec 2013

BIOCEPT INC Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2022 -140% -131% -1543% 01 Jan 2022 31 Dec 2022
2021 -8.5% +67% +89% 01 Jan 2021 31 Dec 2021
2020 -76% +143% +65% 01 Jan 2020 31 Dec 2020
2019 -218% +209% +49% 01 Jan 2019 31 Dec 2019
2018 -427% -52% -14% 01 Jan 2018 31 Dec 2018
2017 -375% -1906% -124% 01 Jan 2017 31 Dec 2017
2016 1531% +1724% 01 Jan 2016 31 Dec 2016
2015 -192% +136% +41% 01 Jan 2015 31 Dec 2015
2014 -329% -390% -636% 01 Jan 2014 31 Dec 2014
2013 61% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.